Language access is a patient safety issue and not all AI interpretation platforms are built to the same standard. A practical framework for CMIOs and clinical leaders who need to get this decision right.

For the 25 million limited English proficient patients in the United States, the ability to communicate clearly with a clinician is not a convenience. It is a precondition for safe care. Communication failures are among the leading causes of adverse clinical events and LEP patients consistently bear a disproportionate share of that risk. The question is no longer whether health systems need to solve language access. The question is how and specifically, whether AI-powered medical interpretation is ready to play a central role.

The market for AI medical interpretation has grown rapidly. Vendors are multiplying, claims are expanding and the pressure on CMIOs and clinical informatics leaders to evaluate these platforms with rigor has never been greater. A study published in NEJM Catalyst, which cited platforms including No Barrier, highlighted the growing body of evidence supporting AI-assisted language access in clinical settings and the importance of choosing tools that are built not just for performance, but for compliance, patient safety and genuine human choice.

‍

This guide provides a structured framework for that evaluation. It is organized around the six dimensions that matter most: regulatory foundation, clinical accuracy, the patient's right to choose, workflow integration, risk management and evidence. Each section includes the key questions you should be asking vendors before you sign anything.

‍

1. Why regulatory compliance must come first, not last

Too many health systems evaluate AI interpretation tools the way they evaluate consumer software: starting with the demo, moving to the pricing and checking compliance, checking for integration process.

‍

1.1 Compliance in AI medical interpretation

Section 1557 of the Affordable Care Act is not a paperwork requirement that can be layered onto a product after the fact. It is a legal framework that shapes what an interpretation tool must be and any platform that was not designed with it as a foundation will struggle to meet its requirements in practice.

‍

1.2 What Section 1557 actually requires

Section 1557 prohibits discrimination on the basis of national origin in covered health programs, which the Department of Health and Human Services has interpreted to include language-based discrimination. In practical terms, this means that covered entities (hospitals, health systems, federally funded clinics) must provide meaningful language access to LEP patients at no cost.

They must do so in a timely manner.

And critically, they must preserve the patient's right to a qualified human interpreter at any time, even when AI interpretation is available.

This last requirement is not incidental. It is foundational. A platform that makes human interpretation difficult to access or that treats it as a fallback mode rather than a standing option, is not Section 1557-compliant in spirit and may not be compliant in practice.

When evaluating vendors, ask directly: was your platform designed with Section 1557 as its foundation? The answer reveals a great deal about the product philosophy. It also highlights general interpretation tools from clinical-grade medical interpretation tools. 

‍

1.3 HIPAA, data governance and the BAA question

Beyond Section 1557, any AI interpretation platform is handling protected health information in real time. Clinical conversations include diagnoses, medications, treatment plans and patient-identifying details. The platform must be HIPAA-compliant and the vendor must be prepared to sign a Business Associate Agreement before any pilot deployment, not after. Platforms that hesitate on the BAA or that route conversation data through third-party servers without clear data governance documentation, should be removed from consideration.

Ask vendors to provide their SOC 2 Type II report or equivalent security certification, their data retention policy and documentation of how conversation data is stored, used and deleted. These are not optional disclosures. They are minimum requirements for any health system deploying AI at the point of care.

‍

1.4 Audit trails and documentation requirements

Compliance in a clinical setting is not a one-time certification. It is an ongoing operational responsibility. Your AI interpretation platform needs to generate reliable encounter-level audit trails that can support compliance review, quality improvement and if necessary, regulatory inquiry. Every interpretation session should be logged with timestamps, language pairs, clinician identifiers and a record of whether the patient requested or was offered a human interpreter. If a vendor cannot describe their audit trail capability in specific, concrete terms, treat that as a significant risk.

‍

1.5 Clinical accuracy is not the same as translation accuracy

This is the most consequential misunderstanding in AI medical interpretation procurement. General-purpose translation engines (even very good ones such as Google Translate, chatGPT etc) are not trained for clinical language. Medical terminology is dense, domain-specific and context-dependent in ways that general NLP models are not designed to handle. The word "positive" means something entirely different in an oncology report than it does in a general conversation. Dosing instructions require exact language. Informed consent discussions depend on nuance that cannot be flattened or approximated.

When vendors present accuracy benchmarks, the first question to ask is: accuracy on what? Benchmarks from controlled translation tasks are not the same as validated accuracy in deployed clinical settings. Look for platforms that can provide peer-reviewed data that document real-world performance, not just lab conditions.

‍

1.6 Medical terminology and specialty-specific language

A platform that performs well for general primary care conversations may underperform significantly in cardiology, oncology, behavioral health or emergency medicine. All of which have highly specialized vocabularies and high-stakes communication requirements.

Ask vendors to demonstrate accuracy specifically in the clinical specialties most relevant to your patient population.

‍

‍

2. Low-resource languages and underserved populations

The LEP patients who face the greatest barriers to care are often speakers of languages that are underrepresented in general NLP training data. Indigenous languages, regional dialects and languages with smaller digital corpora.

Evaluating a platform only on its performance in Spanish, Mandarin, French or Arabic will not tell you how it performs for the patients who need the most support.

‍

2.1 Language Support & Health Equity Considerations

When evaluating vendors, request a complete language support list; not just the number of languages but the depth of coverage within each one.

Spanish, for example, encompasses meaningfully distinct dialects: Mexican Spanish, Dominican Spanish, Puerto Rican Spanish and others. A solution that supports "Spanish" without accounting for these differences may still leave patients underserved.

‍

2.2 Ask what happens when a patient's language isn't covered‍

Some vendors, such as No Barrier, address this through human escalation to partner traditional language service providers; ensuring that the care workflow is never disrupted and that both provider and patient remain fully supported regardless of the language needed.

This is a critical differentiator.

Vendors claiming support for 200+ languages often achieve this through a hybrid model combining AI interpretation with escalation to human interpreters, which is worth clarifying upfront.

‍

2.3 Low-resource languages

This brings us to a third, closely related question: how is accuracy validated for low-resource languages? Languages like Marshallese or Tigrinya (Eritrean) have limited training data which directly affects AI performance. This is not a criticism of vendors; it is simply an awareness of what AI can realistically deliver today and where its limits lie.

Tigrinya-certified medical interpreters are rare and so is the data needed to train a reliable AI model. This is a configuration challenge, not a failure.

Ask vendors what their roadmap looks like for expanding coverage and, crucially, whether that expansion is feasible given the resources and data required to do it responsibly.‍

‍

TL;DR Building your language access plan means understanding both what the market can currently offer. AI medical interpretation combined with human escalation and where its limits lie, particularly for rarer languages. Choosing the right vendor is not simply about selecting an AI medical interpretation service; it is about defining who will ensure the continuity of your care operations and provide a comprehensive solution that bridges language access for the full patient population you serve.

‍

‍

3. Peer review and the evidence standard

In a rapidly commercializing market, peer-reviewed clinical citation is a meaningful differentiator. When a platform appears in indexed clinical research; as No Barrier did in the NEJM Catalyst study on language access in healthcare, that citation represents independent external validation that is qualitatively different from vendor-produced marketing materials. It means the platform has been examined by researchers with no commercial stake in the outcome, that the methodology was subject to editorial review and that the findings are reproducible.

‍

3.1 Human choice is not an escalation pathway. It is a right

This is the area where AI interpretation platforms differ most sharply from one another and where the stakes for patients are highest. There is a category of vendor that treats human interpretation as a fallback: something that kicks in when the AI fails, when a risk threshold is crossed or when a provider decides the situation warrants it.

And there is a different category of vendor that treats human interpretation as a standing choice. Something the patient or provider can select at any moment, for any reason, without friction and without justification.

The difference between these two philosophies is not subtle. The first treats AI as the default and human interpretation as the exception. The second treats patient autonomy as the default and AI as a tool in service of it. Section 1557 supports the second philosophy. And so does basic clinical ethics.

The freedom to choose is built into every stage of the encounter. Before or at any point during a visit, either the patient or the provider can opt for a qualified human interpreter instead of AI. This flexibility ensures that every individual's comfort and communication needs are fully respected. No one is ever locked into AI interpretation.

‍

3.2 What patient-initiated choice looks like in practice

A patient who is uncomfortable with AI interpretation (for any reason, including cultural preference, mistrust of technology, anxiety or simply a sense that the conversation is too sensitive to leave to a machine) must be able to request a human interpreter without having to justify that request, navigate a complex workflow or accept a significant delay in care. That transition should be seamless, immediate and documented.

Ask vendors to walk you through the patient-facing experience of requesting a human interpreter. The number of steps required and the time to transition are revealing. Using No Barrier, you just need to click on "Human". 

‍

3.3 Provider-initiated escalation without workflow disruption

Providers must also be able to initiate a transition to human interpretation without leaving the EHR, without disrupting the clinical encounter and without imposing additional friction on the patient. A provider who senses that a conversation about informed consent, a sensitive diagnosis or end-of-life care requires a human presence should be able to make that transition in a single action.

If a vendor's answer to this question involves multiple screen or a separate application that is a workflow design failure with real clinical consequences.

‍

3.4 No Barrier and the principle of built-in choice

No Barrier was built with Section 1557 as its foundation. Not as a compliance layer but as a design philosophy. The platform does not treat human escalation as a safety valve or an edge case. Human choice is a core architectural feature: the right to transition to a qualified human interpreter is preserved at every moment of every encounter, for every patient.

‍

‍

4. A practical evaluation framework for CMIOs

The six dimensions below represent the complete evaluation surface for AI medical interpretation. Use them to structure your RFP, your vendor demos and your final scoring.

4.1 The six-dimension scoring framework

CMIO evaluation checklist for AI medical interpretation:

• Regulatory compliance: Section 1557 as foundational architecture, HIPAA BAA availability, encounter-level audit trails, full language coverage for your patient population
• Clinical accuracy: peer-reviewed validation in indexed journals, specialty-specific language support, real-world (not lab-only) performance data
• Human choice and escalation: patient-initiated and provider-initiated transition to human interpreter
• EHR and workflow integration: integration with your EHR platform, mobile and bedside accessibility
• Risk management: uncertainty detection, provider notification for high-risk scenarios
• Cost: scalable and predictable as LEP population is growing

‍

AI medical interpretation is already growing across the US healthcare industry. Small clinics, community health centers and remote care settings have embraced it for its simplicity, immediacy and accessibility.

Larger health systems, meanwhile, are building structured protocols around it, defining when AI interpretation is appropriate and when a human interpreter is needed. Some draw that line based on clinical risk level; others factor in urgency, recognizing that in an emergency, seconds matter.

In practice, choosing AI interpretation means choosing a hybrid model: one system that guarantees continuity, deploying AI and human interpreters each where they are most needed.